"Designing Growth Strategies is in our DNA"

Asia Pacific Advanced Wound Care Market Size, Share, Trends & & Industry Analysis, By Product Type (Advanced Wound Dressings {Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings, Others}, Wound Care Devices {Negative Pressure Wound Therapy (NPWT), Hyperbaric Oxygen Therapy (HBOT), Others}, and Active Wound Care {Biological Skin Equivalents, Growth Factors, Others}), By Indication (Diabetic Foot Ulcers, Others), By End User (Hospitals, Clinics, Homecare Settings, Others), and Regional Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI107578

 

Asia Pacific Advanced Wound Care Market Size & Share

Play Audio Listen to Audio Version

Asia Pacific is the fastest-growing region in the global advanced wound care market. The Asia Pacific advanced wound care market size is projected to grow at a CAGR of 6.3% during the forecast period. The global market is projected to grow from USD 11.38 billion in 2022 to USD 17.48 billion by 2030.

Increasing initiatives by the key players to obtain reimbursement for their advanced wound care products in the region are anticipated to raise the adoption of these products in the forthcoming years. For instance, in September 2022, MiMedx, a biologics company, received reimbursement approval for Epifix from the Japanese Ministry of Health, Labor and Welfare (JMHLW) to treat diabetic and venous leg ulcers.

Our report on the Asia Pacific market covers the following countries/regions – India, China, Japan, Australia, Southeast Asia, and the rest of Asia Pacific.

ASIA PACIFIC ADVANCED WOUND CARE MARKET LATEST TRENDS

Shifting Focus of Leading Manufacturers to Expand Geographical Footprint to Propel Industry Growth

The Asia Pacific advanced wound care market is witnessing a substantial growth owing to the rising focus by the players to launch wound care products in order to meet the increasing demand. Moreover, the players are continuously engaging in activities to strengthen their presence in the region by establishing manufacturing facilities and collaborating with government and non-government organizations to increase their production capacity and raise awareness among the population for efficient wound care management. Moreover, the researchers and key players are also shifting their focus to develop next-generation wound care products to cater to the unmet needs of available wound care products.

  • For instance, in September 2021, MDM Wound Ventures, a U.S. based company entered into a distribution agreement with UCT Medical Co. Ltd. in South Korea to launch EZ Debride, a wound care device.

DRIVING FACTORS

Increasing Prevalence of Chronic and Acute Wounds in the Region to Raise the Demand

The increasing burden of the geriatric population, coupled with the rising prevalence of various chronic disorders, is one of the predominant factors contributing to the rising demand for these products. Chronic disorders such as diabetes, prolonged ICU admission, and injuries such as spinal cord injury increase the risk of developing chronic wounds among patients. Advanced wound care products are effective in the treatment of these conditions. Thus, the rising prevalence of chronic wounds along with chronic diseases augments the Asia Pacific advanced wound care market growth.

  • For instance, according to data published by the Australian Government in 2021, approximately 16% of the total population were 65 years old and above.

RESTRAINING FACTORS

Download Free sample to learn more about this report.

High Cost of Wound Treatment to Limit the Market Growth 

Despite the increased demand for these products due to the rising number of patients suffering from chronic and acute wounds, the high cost associated with the treatment and reluctance among patients to continue with the treatment regimen is one of the key factors affecting the market growth. In the Asia Pacific region, chronic wounds impose a significant health care burden with devastating impact and high financial burden.

Furthermore, limited knowledge regarding the proper management of wounds in rural and less developed areas and the use of medicinal plant extracts to treat cuts and wounds is expected to limit the market growth.

KEY INDUSTRY PLAYERS

The Asia Pacific market is competitive due to the presence of regional players, along with foreign manufacturers that have monopolized the market. Smith & Nephew, ConvaTec Group PLC, and 3M, are some players with a leading position in the Asia pacific market. The wide product portfolio of these companies, strong geographical presence in the region along with various initiatives undertaken by companies to strengthen their brand presence and promote wound care treatment are a few factors contributing to their large share in the market.

  • For instance, in November 2021, Smith & Nephew established its first medical education Center in order to support customers across the Asia Pacific. The Center will focus on advanced wound management and other business segments of the company.

Moreover, regional players, such as Healthium Medtech Limited, Axio Biosolutions Pvt. Ltd., and others, are also competing with the global players by introducing technologically advanced products in the region.

LIST OF TOP ASIA PACIFIC ADVANCED WOUND CARE COMPANIES:

KEY INDUSTRY DEVELOPMENTS:

  • March 2022: Advanced Oxygen Therapy Inc. received approval from the Chinese National Medical Products Administration (NMPA) for cyclically pressurized wound therapy intended to treat diabetic foot ulcers among patients.
  • September 2021: Human Biosciences planned to launch skin temp and Medfil in India. The launch would help the company to expand its geographical presence and cater to the rising demand for advanced wound care.

REPORT COVERAGE

To gain extensive insights into the market, Download for Customization

The report provides qualitative and quantitative insights on the market and a detailed analysis of the market share, size & growth rate for all possible segments in the market. Along with market forecast, the report provides an elaborative analysis of the market dynamics and competitive landscape. Various key insights presented in the report are overview of the number of procedures, an overview of price analysis of types of products, overview of the regulatory scenario by key countries, pipeline analysis, new product launches, and key industry developments – mergers, acquisitions & partnerships, and the impact of COVID-19 on the market.

Report Scope & Segmentation

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2030

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 6.3% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Product Type; By Indication; By End User; and Country/Sub-Region

By Product Type

  • Advanced Wound Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Film Dressings
    • Hydrocolloid Dressings
    • Antimicrobial Dressings
    • Foam Dressings
    • Others
  • Wound Care Devices
    • Negative Pressure Wound Therapy (NPWT)
    • Hyperbaric Oxygen Therapy (HBOT)
    • Extracorporeal Shock Wave Therapy (ESWT)
    • Others
  • Active Wound Care
    • Biological Skin Equivalents
    • Growth Factors
    • Biological Dressings
  • Others

By Indication

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Surgical Wounds
  • Others

By End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Others

By Country/Sub-Region

  • India (By Indication)
  • China (By Indication)
  • Japan (By Indication)
  • Australia (By Indication)
  • Southeast Asia (By Indication)
  • Rest of Asia Pacific (By Indication)


Frequently Asked Questions

Growing at a CAGR of 6.3%, the market will exhibit steady growth in the forecast period (2023-2030).

Growing burden of various wound cases, rising prevalence of chronic disorders and acute injuries, increase in approval for reimbursement, increase in wound care treatment in home care settings, and rising initiatives to develop new products through research & development are key factors expected to propel the market.

Smith & Nephew, 3M, and ConvaTec Group PLC are the major players in the Asia Pacific market.

China dominated the market in 2022.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 109
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann